ABIONYX Pharma stock | Growth outlook for 2026 & price target

ABIONYX Pharma

ENXTPA:ABNX

€ 3,62

+ €0,15 (4,32%)

3,62 €

+€0,15 (4,32%)

End-of-day quote: 04/08/2026

ABIONYX Pharma Stock Value

The current analyst rating for ENXTPA:ABNX is Buy.

Buy

ABIONYX Pharma Company Info

EPS Growth 5Y

-17,97%

Market Cap

€0,13 B

Long-Term Debt

€0,00 B

Quarterly earnings

05/22/2026 (E)

Dividend

€0,00

Dividend Yield

0,00%

Founded

2005

Industry

Health Care

Country

France

Website

ABIONYX Pharma

ISIN Number

FR0012616852

Website

http://abionyx.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

€10,50

190.06%

Last Update: 04/09/2026

Analysts: 2

Highest Price Target €11,00

Average Price Target €10,50

Lowest Price Target €10,00

In the last five quarters, ABIONYX Pharma’s Price Target has fallen from €12,60 to €11,50 - a -8,73% decrease. Two analysts predict that ABIONYX Pharma’s share price will increase in the coming year, reaching €10,50. This would represent an increase of 190,06%.

Top growth stocks in the health care sector (5Y.)

What does ABIONYX Pharma do?

ABIONYX Pharma SA, a biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases. Business Segments The company’s business segments are structured around the research, development, and commercialization of pharmaceutical products, with a particular emphasis on innovative therapies, such as Bio-HDL. The company’s activities are organized into several key areas, each of which plays a critical role in the overall value chain of pharmaceutical product...

ABIONYX Pharma SA, a biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases.

Business Segments

The company’s business segments are structured around the research, development, and commercialization of pharmaceutical products, with a particular emphasis on innovative therapies, such as Bio-HDL. The company’s activities are organized into several key areas, each of which plays a critical role in the overall value chain of pharmaceutical product development.

The first segment is research and development, which encompasses the discovery and preclinical evaluation of new therapeutic compounds. This segment is responsible for identifying promising drug candidates, conducting laboratory and animal studies to assess their safety and efficacy, and advancing the most promising candidates into clinical development.

The second segment is clinical development, which involves the design and execution of clinical trials to evaluate the safety and efficacy of new drug candidates in human subjects.

Business Strategy

The company’s business strategy is centered on the development and commercialization of innovative pharmaceutical products that address unmet medical needs. The company’s strategy is underpinned by a commitment to scientific excellence and innovation. The company invests heavily in research and development to identify and develop new therapeutic solutions that have the potential to improve patient outcomes. The company’s business strategy is also informed by ongoing analysis of market trends and competitive dynamics. The company continuously monitors the external environment to identify emerging opportunities and threats and to adapt its strategy as needed to maintain its competitive position.

Products and Services

The company’s products and services are focused on the research, development, and commercialization of pharmaceutical products, with a particular emphasis on innovative therapies such as Bio-HDL. The company’s product portfolio includes drug candidates in various stages of development, from preclinical research to clinical trials and regulatory submission.

The company’s services include the design and execution of clinical trials to evaluate the safety and efficacy of new drug candidates, as well as the preparation and submission of regulatory dossiers to obtain marketing authorization and reimbursement.

The company’s services also include the provision of scientific and medical information to prescribers, patients, and other stakeholders, as well as the implementation of marketing and market access strategies to drive adoption and reimbursement of its products.

Geographical Markets

The company operates in multiple geographical markets, with a focus on obtaining regulatory approvals and securing reimbursement in key jurisdictions such as the European Union and the United States.

Customers

The company’s customers include prescribers, patients, government authorities, and third-party payers, who are the primary stakeholders in the adoption and reimbursement of the company’s products.

Sales and Marketing

The company’s sales and marketing activities are focused on promoting its products to prescribers, patients, and payers, as well as securing reimbursement and driving adoption in target markets. The company’s commercial operations are supported by a dedicated sales force, marketing campaigns, and engagement with key opinion leaders in the medical community.

The company’s marketing strategy includes the implementation of scientific publication strategies, support from key opinion leaders, and the development of competitive products for the same indications.

History

The company was founded in 2005. It was incorporated in 2005. The company was formerly known as Cerenis Therapeutics Holding SA and changed its name to ABIONYX Pharma SA in August 2019.

New support ticket

Explore

ABIONYX Pharma Stock Value

ABIONYX Pharma Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does ABIONYX Pharma do?

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

ABIONYX Pharma Stock Value

ABIONYX Pharma Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does ABIONYX Pharma do?

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.